Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - S*BIO
More »

  • GEN | Biolinks
    ... SUNY Upstate Medical University SuppreMol Susavion Biosciences Sutro Biopharma SwedenBIO Swiss Biotech Association Symphogen Syndax Synthetic Genomics TA Instruments Taiwan ...
  • Lucky 13 Serial Entrepreneurs
    ... Humanyx -Co-founder. Launched to create human therapeutic antibody candidates against disease targets. StormBio -Co-founder; Chief Scientific Officer. Launched 2006 to develop ...
    11-12-2012
  • Sharing the Real Synthetic Biology
    ... The myths and misinformation surrounding synbio must be addressed and corrected in every venue if the achievements of the field are to stand out over the reverberations of the echo ...
    8-21-2012
  • Synthetic Biology Brouhaha
    What would happen if a synbio creation were to make its way into the environment? I am not talking about an apocalyptic scenario, which I am sure some synbio opponents consider a ...
    8-21-2012
  • Stem Cell Applications Hasten into the Clinic
    Stroke SanBio began clinical trials last September for SB623, a therapy that restores ... Other projects using this same platform are in the early stages of development. SanBio has ...
    1-15-2012
  • From Russia with Drugs and Vaccines, as Federation and Big Pharma...
    ... SynBio is a RUB 3.2 billion (about $104.15 million), four-year public-private partnership ... HSCI, which holds a 28% stake in SynBio, was joined by Russian-owned Pharmsynthez, ...
    12-1-2011
  • Advertorial: Seahorse Bioscience
    ... as the human lifespan increases. Seahorse Bioscience 16 Esquire Road Billerica, MA 01862 Phone 978.671.1600 Website www.seahorsebio.com Date Founded 2001 Number of Employees 140
    10-1-2011
  • SymBio Inks Deal for Japanese and Korean Rights to Onconova's...
    SymBio Pharmaceuticals negotiated rights to develop Onconova Therapeutics' rigosertib ... agreement with Onconovoa, Tokyo-based SymBio has an exclusive license to develop and ...
    7-8-2011
  • DSP Nabs U.S. and Canadian Marketing Option to SanBio's Phase...
    SanBio is exploiting its NDR(tm) technology to develop bone marrow-derived allogeneic cell ... SanBio claims preclinical studies confirm that when injected into neural tissue, SB623 ...
    10-4-2010
  • Exorcising "Sin" from Synthetic Bio
    But we can now say that synbio (as it's commonly called) has landed squarely in the public ... argued the case for fewer restraints on synbio, at one point implying humans need all ...
    3-15-2010
  • BioAlliance Gets Swiss Regulatory Okay for Oral Candidasis Drug
    terminated its licensing agreement with SpeBio (a joint venture with SpePharm), ... BioAlliance also initiated legal proceedings against SpeBio, citing the latter's violation ...
    8-25-2009
  • Synthetic Bio's Promise Places It on Fast Track
    Synthetic biology, or synbio, has leapt into scientific, commercial, and social discourse ... is developing synbio pathways to biofuels, plastics, rubber, adhesives, and cosmetics. ...
    4-15-2009
  • Conquering RNAi Delivery Challenges
    ... Ph.D., vp research, SanBio (www.san-bio.com). "Epigeneticists have known about this phenomenon for some time, but the idea to apply it to therapeutics for humans is quite new. ...
    7-1-2008
  • Cephalon Gets FDA Nod for Novel CLL Chemotherapy
    tradename Ribomustin in indolent non-Hodgkin's lymphoma, multiple myeloma, and CLL. SymBio Pharmaceuticals holds exclusive rights to develop and market the API in Japan and ...
    3-21-2008
  • Assay: Measurement of Mitochondrial Function
    ... Both assays are destructive and lack kinetic information. Seahorse Bioscience (www.seahorsebio.com) recently introduced a new, label-free, assay system-the XF24 Extracellular Flux ...
    11-1-2007
  • Journal Articles

  • Alternative Polyadenylation in Glioblastoma Multiforme and Changes...
    Biaoyang Lin, Jiaofang Shao, Jing Zhang, Zengming Zhang, Huawei Jiang, Xiaoyan Lou, Gregory Foltz, Qing Lan, Qiang Huang, Bingding Huang
    OMICS: A Journal of Integrative Biology
    and further developed a computational pipeline, RNAelements (http://sysbio.zju.edu.cn/RNAelements/), using covariance model from known RNA binding protein (RBP) ...

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll